vs
Side-by-side financial comparison of QuidelOrtho Corp (QDEL) and Construction Partners, Inc. (ROAD). Click either name above to swap in a different company.
Construction Partners, Inc. is the larger business by last-quarter revenue ($809.5M vs $699.9M, roughly 1.2× QuidelOrtho Corp). Construction Partners, Inc. runs the higher net margin — 2.1% vs -104.7%, a 106.9% gap on every dollar of revenue. On growth, Construction Partners, Inc. posted the faster year-over-year revenue change (44.1% vs -3.7%). Construction Partners, Inc. produced more free cash flow last quarter ($47.1M vs $-94.7M). Over the past eight quarters, Construction Partners, Inc.'s revenue compounded faster (47.6% CAGR vs -2.9%).
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
Alexander Construction Company was a Palm Springs, California, residential development company that built over 2,200 houses in the Coachella Valley of Riverside County, California, between 1955 and 1965.
QDEL vs ROAD — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $699.9M | $809.5M |
| Net Profit | $-733.0M | $17.2M |
| Gross Margin | — | 15.0% |
| Operating Margin | -100.7% | 6.2% |
| Net Margin | -104.7% | 2.1% |
| Revenue YoY | -3.7% | 44.1% |
| Net Profit YoY | -3583.4% | 663.9% |
| EPS (diluted) | $-10.78 | $0.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $809.5M | ||
| Q3 25 | $699.9M | $899.8M | ||
| Q2 25 | $613.9M | $779.3M | ||
| Q1 25 | $692.8M | $571.6M | ||
| Q4 24 | $707.8M | $561.6M | ||
| Q3 24 | $727.1M | $538.2M | ||
| Q2 24 | $637.0M | $517.8M | ||
| Q1 24 | $711.0M | $371.4M |
| Q4 25 | — | $17.2M | ||
| Q3 25 | $-733.0M | $56.6M | ||
| Q2 25 | $-255.4M | $44.0M | ||
| Q1 25 | $-12.7M | $4.2M | ||
| Q4 24 | $-178.4M | $-3.1M | ||
| Q3 24 | $-19.9M | $29.3M | ||
| Q2 24 | $-147.7M | $30.9M | ||
| Q1 24 | $-1.7B | $-1.1M |
| Q4 25 | — | 15.0% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 16.9% | ||
| Q1 25 | — | 12.5% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 15.6% | ||
| Q2 24 | — | 16.1% | ||
| Q1 24 | — | 10.4% |
| Q4 25 | — | 6.2% | ||
| Q3 25 | -100.7% | 11.2% | ||
| Q2 25 | -29.4% | 10.6% | ||
| Q1 25 | 4.7% | 4.8% | ||
| Q4 24 | -14.2% | 2.5% | ||
| Q3 24 | 2.1% | 8.5% | ||
| Q2 24 | -18.4% | 8.8% | ||
| Q1 24 | -247.3% | 0.8% |
| Q4 25 | — | 2.1% | ||
| Q3 25 | -104.7% | 6.3% | ||
| Q2 25 | -41.6% | 5.7% | ||
| Q1 25 | -1.8% | 0.7% | ||
| Q4 24 | -25.2% | -0.5% | ||
| Q3 24 | -2.7% | 5.4% | ||
| Q2 24 | -23.2% | 6.0% | ||
| Q1 24 | -239.9% | -0.3% |
| Q4 25 | — | $0.31 | ||
| Q3 25 | $-10.78 | $1.03 | ||
| Q2 25 | $-3.77 | $0.79 | ||
| Q1 25 | $-0.19 | $0.08 | ||
| Q4 24 | $-2.54 | $-0.06 | ||
| Q3 24 | $-0.30 | $0.55 | ||
| Q2 24 | $-2.20 | $0.59 | ||
| Q1 24 | $-25.50 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $98.1M | $104.1M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $969.1M |
| Total Assets | $5.7B | $3.4B |
| Debt / EquityLower = less leverage | 1.23× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $104.1M | ||
| Q3 25 | $98.1M | $156.1M | ||
| Q2 25 | $151.7M | $114.3M | ||
| Q1 25 | $127.1M | $101.9M | ||
| Q4 24 | $98.3M | $132.5M | ||
| Q3 24 | $143.7M | $74.7M | ||
| Q2 24 | $107.0M | $56.3M | ||
| Q1 24 | $78.5M | $48.0M |
| Q4 25 | — | — | ||
| Q3 25 | $2.5B | $1.6B | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.2B | $515.0M | ||
| Q2 24 | $2.2B | — | ||
| Q1 24 | $2.2B | — |
| Q4 25 | — | $969.1M | ||
| Q3 25 | $2.0B | $912.0M | ||
| Q2 25 | $2.8B | $853.3M | ||
| Q1 25 | $3.0B | $807.9M | ||
| Q4 24 | $3.0B | $811.1M | ||
| Q3 24 | $3.2B | $573.7M | ||
| Q2 24 | $3.2B | $552.9M | ||
| Q1 24 | $3.3B | $525.0M |
| Q4 25 | — | $3.4B | ||
| Q3 25 | $5.7B | $3.2B | ||
| Q2 25 | $6.4B | $2.9B | ||
| Q1 25 | $6.5B | $2.8B | ||
| Q4 24 | $6.4B | $2.6B | ||
| Q3 24 | $6.8B | $1.5B | ||
| Q2 24 | $6.7B | $1.4B | ||
| Q1 24 | $6.7B | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | 1.23× | 1.78× | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.70× | — | ||
| Q4 24 | 0.72× | — | ||
| Q3 24 | 0.68× | 0.90× | ||
| Q2 24 | 0.70× | — | ||
| Q1 24 | 0.68× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-45.5M | $82.6M |
| Free Cash FlowOCF − Capex | $-94.7M | $47.1M |
| FCF MarginFCF / Revenue | -13.5% | 5.8% |
| Capex IntensityCapex / Revenue | 7.0% | 4.4% |
| Cash ConversionOCF / Net Profit | — | 4.80× |
| TTM Free Cash FlowTrailing 4 quarters | $-153.1M | $186.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $82.6M | ||
| Q3 25 | $-45.5M | $112.0M | ||
| Q2 25 | $-46.8M | $83.0M | ||
| Q1 25 | $65.6M | $55.6M | ||
| Q4 24 | $63.7M | $40.7M | ||
| Q3 24 | $117.9M | $95.9M | ||
| Q2 24 | $-97.9M | $34.6M | ||
| Q1 24 | $-700.0K | $18.2M |
| Q4 25 | — | $47.1M | ||
| Q3 25 | $-94.7M | $78.9M | ||
| Q2 25 | $-84.3M | $46.4M | ||
| Q1 25 | $9.4M | $14.2M | ||
| Q4 24 | $16.5M | $13.8M | ||
| Q3 24 | $71.4M | $78.4M | ||
| Q2 24 | $-133.2M | $19.7M | ||
| Q1 24 | $-66.8M | $-10.6M |
| Q4 25 | — | 5.8% | ||
| Q3 25 | -13.5% | 8.8% | ||
| Q2 25 | -13.7% | 5.9% | ||
| Q1 25 | 1.4% | 2.5% | ||
| Q4 24 | 2.3% | 2.5% | ||
| Q3 24 | 9.8% | 14.6% | ||
| Q2 24 | -20.9% | 3.8% | ||
| Q1 24 | -9.4% | -2.8% |
| Q4 25 | — | 4.4% | ||
| Q3 25 | 7.0% | 3.7% | ||
| Q2 25 | 6.1% | 4.7% | ||
| Q1 25 | 8.1% | 7.2% | ||
| Q4 24 | 6.7% | 4.8% | ||
| Q3 24 | 6.4% | 3.3% | ||
| Q2 24 | 5.5% | 2.9% | ||
| Q1 24 | 9.3% | 7.7% |
| Q4 25 | — | 4.80× | ||
| Q3 25 | — | 1.98× | ||
| Q2 25 | — | 1.88× | ||
| Q1 25 | — | 13.20× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.27× | ||
| Q2 24 | — | 1.12× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
QDEL
| Labs | $373.8M | 53% |
| Point Of Care | $164.6M | 24% |
| Immunohematology | $142.0M | 20% |
| Donor Screening | $14.7M | 2% |
| Molecular Diagnostics | $4.8M | 1% |
| Collaborative Arrangement Transaction With Party To Collaborative Arrangement | $2.1M | 0% |
ROAD
Segment breakdown not available.
